Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: persons (497), folks (1)

Audit and Risk Committee ToR Jan 2023

Description: Audit and Risk Committee Terms of Reference Version: 5 Date Issued: Review Date: Document Type: 31 January 2023 January 2024 Committee Ter
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Audit-and-Risk-Committee-ToR-Jan-2023.pdf

Atezolizumab-Bevacizumab

Description: Chemotherapy Protocol Hepatocellular Cancer ATEZOLIZUMAB-BEVACIZUMAB Regimen  HCC-Atezolizumab-Bevacizumab Indication  Atezolizumab in combination with bevacizumab for the first-line systemic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Atezolizumab-Bevacizumab.pdf

Abdominal aortic aneurysm repair - patient information

Description: Information about abdominal aortic aneurysm repair
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Abdominal-aortic-aneurysm-repair-1654-PIL.pdf

SoAR NMAHP-HCS ACDL EOI 2022

Description: Southampton Academy of Research (SoAR) Academic Career Development Lead for Nurses, Midwives and Allied Health Professionals (NMAHPs) & Healthcare Scientist (HCS) Research
Url: /Media/Southampton-Clinical-Research/Downloads/SoAR-NMAHP-HCS-ACDL-EOI-2022.pdf

RCVP-Cyclophosphamide-Prednisolone-Rituximab-Vincristine Ver 1.2

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-PREDNISOLONE-RITUXIMAB-VINCRISTINE (RCVP) Regimen Lymphoma – RCVP-Cyclophosphamide-Prednisolone-Rituximab-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RCVP-Cyclophosphamide-Prednisolone-Rituximab-Vincristine-Ver-1.2.pdf

Audit and Risk Committee ToR Jan 2022

Description: Audit and Risk Committee Terms of Reference Date Issued: 27 January 2022 Review Date: January 2023 Document Type: Committee Terms of Refer
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Audit-and-Risk-Committee-ToR-Jan-2022.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone weekly Cycles 9 onwards

Description: Chemotherapy Protocol Myeloma DVd (weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 9 onwards) Regimen • Myeloma – Bortezomib (weekly) with daratumumab and dexamethasone Indication • Daratumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-weekly-Cycles-9-onwards.pdf

MDT Leaflet_Young Lives vs Cancer Eligibility Criteria 2021

Description: YOUNG LIVES VS CANCER ELIGIBILITY FOR HEALTH PROFESSIONALS YOUNG LIVES VS CANCER: WHO WE ARE Cancer is shocking, overwhelming, isolating... and
Url: /Media/UHS-website-2019/Docs/Services/Cancer-care/mdt-leaflet-young-lives-vs-cancer-eligibility-criteria-2021.pdf

Thumb spica splint - patient information

Description: A thumb spica splint is designed to be used during the day when support isneeded and when you do things with
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Thumb-spica-splint-1825-PIL.PDF

Research Engagement Internship Application Form September 2021

Description: UHS Research Engagement Internship 2022 – Application Form Section 1 – To be completed by the Applicant Name: Click or tap here to
Url: /Media/Southampton-Clinical-Research/Downloads/Research-Engagement-Internship-Application-Form-September-2021.docx

351 to 360 of 699

Previous … 34 35 36 37 38 … Next